세계의 경경관 난관 불임법 시장 - 규모, 제품별, 용도별, 지역별, 범위 및 예측

Transcervical Tubal Sterilization Market Size And Forecast

Transcervical Tubal Sterilization Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e., 2021 to 2028.

The transcervical Tubal sterilization market growth is driven by changing lifestyles, increased awareness, birth control techniques, and increased disposable income. The Global Transcervical Tubal Sterilization Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Transcervical Tubal Sterilization Market Definition

Sterilization is often chosen as a method of permanent contraception. Traditional approaches involve surgery under anesthesia in an operating room and are associated with a recovery period and scars. Transcervical sterilization or tubal occlusion is an incision-free, minimally invasive procedure alternative to surgical tubal ligation. Compared with laparoscopic surgery, transcervical hysteroscopic sterilization does not need to be performed in an operating room, requires less anesthesia, has a shorter recovery period, and is more cost-effective.

Transcervical tubal sterilization methods have good tubal access, occlusion rates, high patient acceptability and are performed in an outpatient environment. This combination of factors may offer significant benefits to traditional laparoscopic approaches and render them more cost-effective.

Global Transcervical Tubal Sterilization Market Overview

The growing awareness for birth control across the globe is expected to boost the growth of the market. The primary factor that plays a significant role in driving the market is that this process does not show any side effects that consist of birth control pills and is the safest contraceptive method. Further, the technological advancements by the various market players to enhance the procedure of sterilization and the awareness drives by the market players currently done are focused on constant up-gradation and improvement of the quality of operation of Transcervical Tubal Sterilization being provided to the women. Moreover, the factor such as there's no incision involved in the procedure can be performed in an office setting. Hence, it is more cost- and time-effective, has Minimal to no anesthetic requirements, can be performed in women with extensive pelvic adhesions, causes Less post-operative pain, it can be completed in women with co-morbidities that preclude laparoscopy or laparotomy are responsible for the growth of Global Transcervical Tubal Sterilization Market during the forecast period.

The factors such as the risk of complications and long recovery period are challenges that may negatively impact the market's growth. Moreover, the element such as process is irreversible. It is a permanent method, and only a few changes are reversible-the absence of protection against sexually transmitted diseases restraint the market's growth. Need for contraception for 12 weeks post-procedure (until the tubal occlusion is confirmed); The expense of device and imaging study to ensure tubal occlusion; Electrical conductivity of micro-insert limits the use of electrocautery during subsequent pelvic procedures; Higher risk of unilateral tubal occlusion; The need for adequate vaginal surgical training to minimize potential complications are some additional factors that can hinder the global transcervical tubal sterilization market.

The growing awareness about family planning and the advancement of new technologies involved in Transcervical Tubal Sterilization that reduce the risk of STDs might generate new opportunities within the forecast period.

Global Transcervical Tubal Sterilization Market: Segmentation Analysis

The Global Transcervical Tubal Sterilization Market is segmented based on Product, Application, and Geography.

Transcervical Tubal Sterilization Market by Product

• Tubal Ligation
• Transcervical Implants

Based on the product, the global transcervical tubal sterilization market is bifurcated into tubal ligation and transcervical implants. Tubal ligation dominates this segment of the global transcervical tubal sterilization market, owing to governments' sponsorship to control the country's populations. This kind of female sterilization needs a laparoscopic incision to be made in the abdominal area to surgically block the fallopian tubes by cutting, tying, or using clamps. This kind of sterilization procedure is effective immediately. The transcervical implant segment is expected to witness steady growth in the forecasted period. As one of the main factors for the development of the market, this procedure involves no surgical incision and hence can be performed in an office setting.

Transcervical Tubal Sterilization Market by Application

• Hospitals
• Clinics
• Others

Based on application, the global transcervical tubal sterilization market is bifurcated into hospitals, clinics, and others. Hospitals dominate this segment owing to prefer in emerging countries not able to afford treatment in clinics that are usually privately managed though clinics are witnessing a steady rise in the global transcervical tubal sterilization market. Moreover, most clinics do not offer such procedures, which are available in almost all of the hospitals everywhere. The presence of clinics is also a factor why the hospital's segment has the majority share in this segment; the number of hospitals is enormous compared to the number of hospitals.

Transcervical Tubal Sterilization Market by Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on geography, the global transcervical tubal sterilization market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the world. North American market leads the transcervical tubal sterilization market in terms of revenue share, owing to awareness among the general population and increasing promotion for family planning activities from the government. Europe market held the second largest market share of the global transcervical tubal sterilization market in terms of sales, followed by the market in the Asia Pacific.

Key Players

The "Global Transcervical Tubal Sterilization Market" study report will provide valuable insight emphasizing the global market. The major players in the market are

Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the players mentioned above globally.

Report Scope

Report Attributes

Report Attributes

Study Period

2017-2028

Base Year

2020

Forecast Period

2021-2028

Historical Period

2017-2019

Key Companies Profiled

Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

Segments Covered

By Product, By Application, and By Geography.

Customization scope

Free report customization (equivalent up to 4 analyst's working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Transportation Battery Market Size And Forecast

Training Dancewear Market Size And Forecast

Global Transcervical Tubal Sterilization Market: Research Methodology

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our

sales team

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter's five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support

Customization of the Report

• In case of any

Queries or Customization Requirements

Frequently Asked Questions

What are the key driving factors for the growth of the Transcervical Tubal Sterilization Market?

• The transcervical Tubal sterilization market growth is driven by changing lifestyles, increased awareness, birth control techniques, and increased disposable income.

What are the top players operating in the Transcervical Tubal Sterilization Market?

• Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

What segments are covered in the Transcervical Tubal Sterilization Market?

• The Global Transcervical Tubal Sterilization Market is segmented based on Product, Application, and Geography.
• The sample report of the Transcervical Tubal Sterilization Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porter Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY PRODUCT

• 5.1 Overview
• 5.2 Tubal Ligation
• 5.3 Transcervical Implants

6 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY APPLICATION

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Clinics
• 6.4 Others

7 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Middle East and Africa
  • 7.5.2 Latin America

8 GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Ethicon
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Medtronic
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Applied Medical
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Richard Wolf
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Bayer AG
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Stryker
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Development
• 9.7 LiNA Medical
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 ConMed
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Microline Surgical
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Development
• 9.10 Apollo Endosurgery
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Development

10 Appendix

• 10.1 Related Research